Seattle Children's Hospital (dba Seattle Children's Research Institute);Seattle Childrens Hospital (dba Seattle Childrens Research Institute)
发明人:
Crane, Courtney,Jensen, Michael C.,White Moyes, Kara,Lieberman, Nicole
申请号：
AU2016318773
公开号：
AU2016318773A1
申请日:
2016.09.07
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
Disclosed are methods of making a genetically modified immune cell for modifying a tumor microenvironment (TME) and methods of modifying a tumor microenvironment (TME). In some embodiments, the method can include delivering a first vector to an immune cell, wherein the first vector comprises a nucleic acid encoding a protein that induces T-cell proliferation, promotes persistence and activation of endogenous or adoptively transferred NK or T cells and/or induces production of an interleukin, an interferon, a PD-1 checkpoint binding protein, HMGB1, MyD88, a cytokine or a chemokine. Methods of modulating the suppression of the immune response in a tumor microenvironment, minimizing the proliferation of tumor and suppressive cells, and increasing the efficiency of an anti-cancer therapy, anti-infection therapy, antibacterial therapy, anti-viral therapy, or anti-tumoral therapy are also provided.
